Auranofin/Vitamin C: A Novel Drug Combination Targeting Triple-Negative Breast Cancer.

Author: AzzaroneBruno, AzziSandy, BaldacciGiuseppe, BaïlleDorothée, DingliFlorent, EidPierre, El BannaNadine, HatemElie, HeTiantian, Heneman-MasurelAmélie, HuangMeng-Er, LoewDamarys, MassonVanessa, VernisLaurence

Paper Details 
Original Abstract of the Article :
Cancer cells from different origins exhibit various basal redox statuses and thus respond differently to intrinsic or extrinsic oxidative stress. These intricate characteristics condition the success of redox-based anticancer therapies that capitalize on the ability of reactive oxygen species to ach...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1093/ije/djy149

データ提供:米国国立医学図書館(NLM)

Auranofin/Vitamin C: A Promising Duo in the Fight Against Triple-Negative Breast Cancer

The vast desert of cancer research is constantly evolving, with scientists tirelessly seeking new oases of hope for patients fighting this devastating disease. This study explores the potential of a novel drug combination – auranofin and vitamin C – in targeting triple-negative breast cancer, a particularly aggressive form of the disease. The researchers investigated the effects of this combination on cancer cells, exploring the intricate interplay between oxidative stress and cancer cell death.

A New Approach to Triple-Negative Breast Cancer

The study found that auranofin/vitamin C combination therapy had a significant effect on triple-negative breast cancer cells, demonstrating promising potential for treating this challenging disease. Think of it this way: imagine a desert where a rare and precious oasis exists. The combination of auranofin and vitamin C could be seen as a unique blend of elements that create this oasis of hope for those fighting triple-negative breast cancer.

A Ray of Hope for Triple-Negative Breast Cancer Patients

This study offers a glimmer of hope in the ongoing battle against triple-negative breast cancer. The potential of this combination therapy warrants further investigation, as it could lead to more effective and targeted treatment strategies for this challenging disease.

Dr. Camel's Conclusion

The fight against cancer is a long and arduous journey. Studies like this demonstrate the unwavering commitment of scientists to finding new and innovative ways to improve patient outcomes. This research offers a valuable stepping stone in the quest for effective treatments for triple-negative breast cancer.

Date :
  1. Date Completed n.d.
  2. Date Revised 2022-03-30
Further Info :

Pubmed ID

30462268

DOI: Digital Object Identifier

10.1093/ije/djy149

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.